Clinical trial
Methylation Detection of KCNA3 and OTOP2 Genes in Plasma for the Auxiliary Diagnosis of Esophageal Cancer/Precancerous Lesions: a Clinical Trial
NCT05680077 is registered in ClinicalTrials.gov with Wuhan Ammunition Life-tech Co., Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Methylation Detection of KCNA3 and OTOP2 Genes in Plasma for the Auxiliary Diagnosis of Esophageal Cancer/Precancerous Lesions: a Clinical Trial
- Lead sponsor
- Wuhan Ammunition Life-tech Co., Ltd
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 28, 2022
- Completion date
- October 31, 2023
- Enrollment
- 1,116 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.